{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Adjuvant procedure",
      "Long-term effect",
      "Mechanism of action",
      "Neuromodulatory network",
      "Neurostimulation"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "EINF\u00fcHRUNG: Seit 20\u00a0Jahren ist die Vagusnervstimulation (VNS) eine europaweit zugelassene invasive Therapieoption f\u00fcr therapieresistente Depressionen (TRD). Im Gegensatz zu gel\u00e4ufigeren Behandlungen wie EKT sind Kenntnisse \u00fcber VNS sowohl in der Allgemeinbev\u00f6lkerung als auch in Fachkreisen gering.",
        "In diesem narrativen Review geben wir eine klinisch und wissenschaftlich fundierte \u00dcbersicht \u00fcber die VNS. Hypothesen zum Wirkmechanismus sowie die aktuelle Evidenzlage zur Wirksamkeit werden dargestellt. Das perioperative Management, das Nebenwirkungsprofil und die Nachbetreuung einschlie\u00dflich Dosistitration werden beschrieben. Ein Vergleich \u00fcber internationale Leitlinienempfehlungen zur VNS findet sich ebenfalls. Ferner formulieren wir Kriterien, die bei der Auswahl geeigneter Patienten hilfreich sind.",
        "Die elektrischen Impulse werden \u00fcber den N.\u00a0vagus afferent weitergeleitet und stimulieren \u00fcber verschiedene Wege ein neuromodulatorisches zerebrales Netzwerk. Viele Studien und Fallserien zeigten die Wirksamkeit von VNS als adjuvantes Verfahren bei TRD. Der Effekt tritt mit einer Latenz von 3 bis 12\u00a0Monaten ein und steigt m\u00f6glicherweise mit der Dauer der VNS. Unter der Beachtung der Stimulationsempfehlungen sind die Nebenwirkungen f\u00fcr die meisten Patienten tolerabel.",
        "Die VNS ist eine zugelassene, wirksame und gut vertr\u00e4gliche Langzeittherapie f\u00fcr chronische und therapieresistente Depressionen. Weitere Sham-kontrollierte Studien \u00fcber einen l\u00e4ngeren Beobachtungszeitraum sind zur Verbesserung der Evidenz w\u00fcnschenswert."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35380222",
  "DateCompleted": {
    "Year": "2022",
    "Month": "09",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "09",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "04",
        "Day": "05"
      }
    ],
    "Language": [
      "ger"
    ],
    "ELocationID": [
      "10.1007/s00115-022-01282-6"
    ],
    "Journal": {
      "ISSN": "1433-0407",
      "JournalIssue": {
        "Volume": "93",
        "Issue": "9",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep"
        }
      },
      "Title": "Der Nervenarzt",
      "ISOAbbreviation": "Nervenarzt"
    },
    "ArticleTitle": "[Vagus nerve stimulation for difficult to treat depression].",
    "Pagination": {
      "StartPage": "921",
      "EndPage": "930",
      "MedlinePgn": "921-930"
    },
    "Abstract": {
      "AbstractText": [
        "For the past 20\u00a0years vagus nerve stimulation (VNS) has been an approved invasive treatment option for treatment-resistant depression (TRD) across Europe. In contrast to more common treatments, such as ECT, knowledge about VNS is low both in the general population and among professionals.",
        "In this narrative review, we provide a\u00a0clinically and scientifically sound overview of VNS. Hypotheses on the mechanism of action as well as the current evidence base on efficacy are presented. Perioperative management, adverse event profile and follow-up including dose titration are described. A\u00a0comparison of international guideline recommendations on VNS is also provided. Furthermore, we formulate criteria that are helpful in the selection of appropriate patients.",
        "Electrical impulses are transmitted afferently via the vagus nerve and stimulate a\u00a0neuromodulatory cerebral network via different pathways. Many studies and case series demonstrated the efficacy of VNS as an adjuvant procedure for TRD. The effect occurs with a\u00a0latency period of 3-12\u00a0months and possibly increases with the duration of VNS. If stimulation recommendations are followed, side effects are tolerable for most patients.",
        "The use of VNS is an approved, effective and well-tolerated long-term therapy for chronic and treatment-resistant depression. Further sham-controlled studies over a\u00a0longer observational period are desirable to improve the evidence."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Psychiatrie, Psychosomatik und Psychotherapie, Universit\u00e4tsklinikum Frankfurt\u00a0- Goethe-Universit\u00e4t, Heinrich-Hoffmann-Stra\u00dfe\u00a010, 60528, Frankfurt am Main, Deutschland. christine.reif-leonhard@kgu.de."
          }
        ],
        "LastName": "Reif-Leonhard",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Psychiatrie, Psychosomatik und Psychotherapie, Universit\u00e4tsklinikum Frankfurt\u00a0- Goethe-Universit\u00e4t, Heinrich-Hoffmann-Stra\u00dfe\u00a010, 60528, Frankfurt am Main, Deutschland."
          }
        ],
        "LastName": "Reif",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Psychische Gesundheit, Universit\u00e4tsklinikum M\u00fcnster\u00a0- Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster, M\u00fcnster, Deutschland."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australien."
          },
          {
            "Identifier": [],
            "Affiliation": "The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australien."
          }
        ],
        "LastName": "Baune",
        "ForeName": "B T",
        "Initials": "BT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Psychische Gesundheit, Universit\u00e4tsklinikum M\u00fcnster\u00a0- Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster, M\u00fcnster, Deutschland."
          }
        ],
        "LastName": "Kavakbasi",
        "ForeName": "E",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Vagusnervstimulation bei schwer zu behandelnden Depressionen."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Nervenarzt",
    "NlmUniqueID": "0400773",
    "ISSNLinking": "0028-2804"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "diagnosis",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Vagus Nerve"
    },
    {
      "QualifierName": [
        "adverse effects",
        "methods"
      ],
      "DescriptorName": "Vagus Nerve Stimulation"
    }
  ]
}